Global Obesity Intervention Devices Market Growth (Status and Outlook) 2025-2031

According to this study, the global Obesity Intervention Devices market size will reach US$ 477 million by 2031.

Obesity is a medical condition caused by an increase in fat cells in the body, which can have a negative impact on health. High blood pressure, high cholesterol and heart disease are serious medical conditions associated with obesity. Obesity also increases the risk of certain diseases, such as type 2 diabetes, osteoarthritis, obstructive sleep apnea, and depression. If diet or exercise is not effective, obesity intervention devices can be used to reduce the size of the stomach or the length of the intestine, thereby reducing the ability to absorb nutrients from food.

According to public information, in 2022, there were about 1.2 billion obesity cases worldwide, among them, the number of obesity cases in China reached 230 million. Wellness & Health Research Center, the global sports economy was valued at 750 billion in 2022, 92% of global spending on physical activity occurs in Asia Pacific, North America and Europe. And China and the United States accounted for 44% of total sports spending.

LPI (LP Information)' newest research report, the “Obesity Intervention Devices Industry Forecast” looks at past sales and reviews total world Obesity Intervention Devices sales in 2024, providing a comprehensive analysis by region and market sector of projected Obesity Intervention Devices sales for 2025 through 2031. With Obesity Intervention Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Obesity Intervention Devices industry.

This Insight Report provides a comprehensive analysis of the global Obesity Intervention Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Obesity Intervention Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Obesity Intervention Devices market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Obesity Intervention Devices and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Obesity Intervention Devices.

This report presents a comprehensive overview, market shares, and growth opportunities of Obesity Intervention Devices market by product type, application, key players and key regions and countries.

Segmentation by Type:
Gastric Bands
Electrical Stimulation System
Gastric Balloon System
Gastric Emptying System
Appetite Suppressors

Segmentation by Application:
Hospitals
Gastroenterology clinics
Ambulatory Surgical Centers

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Medtronic
EnteroMedics
Apollo Endosurgery
Cousin Biotech
Aspire Bariatrics
Obalon Therapeutics
GI Dynamics
Johnson and Johnson
Spatz FGIA
Gore Medical
ReShape Lifesciences

Please note: The report will take approximately 2 business days to prepare and deliver. Show more